Geoff Meacham
Citibank's Global Head of Healthcare, providing analysis of pharmaceutical earnings and industry trends.
Best podcasts with Geoff Meacham
Ranked by the Snipd community
Feb 6, 2025 • 47min
Looking Ahead to First US Jobs Report of 2025
Ted Mann, a Bloomberg News Money and Influence reporter, discusses Elon Musk's controversial strategies that are ruffling feathers in the U.S. Treasury. Kevin Jacobs, Hilton's CFO, highlights the company’s record growth and optimistic outlook for the travel sector. Geoff Meacham, Citibank's Global Head of Healthcare, provides insights into pharmaceutical earnings, particularly from Eli Lilly and Pfizer, amid rising industry trends. The conversation sheds light on the economic landscape shaped by these developments.
Nov 20, 2025 • 18min
Episode 56: Thankful for Health - AI, Vaccines, and Weight loss
Geoff Meacham, Global Head of Healthcare at Citi, shares insights on the rapidly evolving healthcare landscape. He discusses AI's expected impact on drug development by 2028-2030 and the potential for increased interest from generalist investors. Geoff also examines the future of GLP-1 drugs, highlighting their shift from injectables to orals, and the implications for patient affordability. The conversation touches on M&A activity in biotech and the evolving pricing strategies in the pharmaceutical sector, making for a compelling listen for healthcare enthusiasts.
